HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Ueda Selected Research

1- (2- (1- adamantyl)ethyl)- 1- pentyl- 3- (3- (4- pyridyl)propyl)urea

2/2010Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents.
4/2009Preventive effect of SA13353 [1-[2-(1-adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea], a novel transient receptor potential vanilloid 1 agonist, on ischemia/reperfusion-induced renal injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Ueda Research Topics

Disease

3Cataract (Cataracts)
01/2018 - 01/2012
3Parkinson Disease (Parkinson's Disease)
01/2009 - 01/2002
2Chronic Disease (Chronic Diseases)
01/2018 - 01/2012
2Heart Neoplasms
01/2018 - 01/2012
2Fatigue
01/2018 - 01/2012
2Macular Degeneration (Age-Related Maculopathy)
01/2018 - 01/2012
2Glaucoma
11/2015 - 01/2012
2Synucleinopathies
01/2009 - 01/2002
1Blindness (Hysterical Blindness)
01/2018
1Neoplasms (Cancer)
10/2013
1Breast Neoplasms (Breast Cancer)
07/2013
1Uveitis
10/2012
1Inflammation (Inflammations)
02/2010
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
02/2010
1Ischemia
04/2009
1Experimental Arthritis
04/2009
1Acute Kidney Injury (Acute Renal Failure)
04/2009
1Memory Disorders (Memory Loss)
10/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2002

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
07/2013 - 01/2002
3alpha-SynucleinIBA
01/2009 - 01/2002
2ZeaxanthinsIBA
01/2018 - 01/2012
2astaxanthine (astaxanthin)IBA
01/2018 - 01/2012
2Biological ProductsIBA
01/2018 - 01/2012
2CosmeticsIBA
01/2018 - 01/2012
21- (2- (1- adamantyl)ethyl)- 1- pentyl- 3- (3- (4- pyridyl)propyl)ureaIBA
02/2010 - 04/2009
2CytokinesIBA
02/2010 - 04/2009
1AntioxidantsIBA
01/2018
1Timolol (Blocadren)FDA LinkGeneric
11/2015
1tafluprostIBA
11/2015
1alpha-naphthylphthalamic acidIBA
10/2013
11-naphthoxyacetic acidIBA
10/2013
1CytokininsIBA
10/2013
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2013
1Indoleacetic Acids (Auxin)IBA
10/2013
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
07/2013
1Sirolimus (Rapamycin)FDA Link
10/2012
1LipopolysaccharidesIBA
02/2010
1Interleukin-10 (Interleukin 10)IBA
04/2009
1Urea (Carbamide)FDA LinkGeneric
04/2009
1resiniferatoxinIBA
04/2009
1Messenger RNA (mRNA)IBA
04/2009
1Superoxides (Superoxide)IBA
04/2009
1Capsaicin (Zostrix)FDA Link
04/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2009
1Transcription Factors (Transcription Factor)IBA
10/2008
1Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA
10/2008
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
10/2008
1TubulinIBA
01/2002

Therapy/Procedure

1Nephrectomy
04/2009